Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tueo Health was a U.S. digital health company focused on improving asthma management, especially in children, through passive physiologic monitoring and software-guided care. The company developed an integrated system combining contactless or sensor-based monitoring, a mobile application, and asthma coaching to help families track symptoms, environment, and treatment response. Originating from Stanford Biodesign work, Tueo positioned its technology as a platform for chronic disease monitoring, with asthma as its initial use case. Tueo Health raised early-stage venture funding and was ultimately acquired by Apple in 2018, after which its team and technology were absorbed into Apple’s health efforts. The company is no longer operating as an independent business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tueo Health.